{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T03:22:37Z","timestamp":1790133757636,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":24,"publisher":"Springer US","isbn-type":[{"value":"9781071641873","type":"print"},{"value":"9781071641880","type":"electronic"}],"license":[{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:00:00Z","timestamp":1729296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4188-0_8","type":"book-chapter","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T14:03:07Z","timestamp":1729260187000},"page":"189-219","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCR"],"prefix":"10.1007","author":[{"given":"Christiane","family":"Pott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Br\u00fcggemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Ritgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H. J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J. M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,19]]},"reference":[{"key":"8_CR1","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1182\/blood-2013-06-507319","volume":"122","author":"M Ladetto","year":"2013","unstructured":"Ladetto M, Lobetti-Bodoni C, Mantoan B et al (2013) Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program. Blood 122:3759\u20133766","journal-title":"Blood"},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1200\/JCO.23.00899","volume":"42","author":"E Hoster","year":"2024","unstructured":"Hoster E, Delfau-Larue MH, Macintyre E et al (2024) Predictive value of minimal residual disease for efficacy of rituximab maintenance in mantle cell lymphoma: results from the European mantle cell lymphoma elderly trial. J Clin Oncol 42:538\u2013549","journal-title":"J Clin Oncol"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.23.00838","volume":"42","author":"C Pott","year":"2024","unstructured":"Pott C, Jurinovic V, Trotman J et al (2024) Minimal residual disease status predicts outcome in patients with previously untreated follicular lymphoma: a prospective analysis of the phase III GALLIUM study. J Clin Oncol 42:550\u2013561","journal-title":"J Clin Oncol"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1182\/blood-2005-07-2845","volume":"107","author":"C Pott","year":"2006","unstructured":"Pott C, Schrader C, Gesk S et al (2006) Quantitative assessment of molecular remission after high-dose therapy with autologous stem cell transplantation predicts long-term remission in mantle cell lymphoma. Blood 107:2271\u20132278","journal-title":"Blood"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1182\/blood-2009-06-230250","volume":"115","author":"C Pott","year":"2010","unstructured":"Pott C, Hoster E, Delfau-Larue MH et al (2010) Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study. Blood 115:3215\u20133223","journal-title":"Blood"},{"key":"8_CR6","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1182\/blood-2002-02-0621","volume":"100","author":"M Ladetto","year":"2002","unstructured":"Ladetto M, Corradini P, Vallet S et al (2002) High rate of clinical and molecular remissions in follicular lymphoma patients receiving high-dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood 100:1559\u20131565","journal-title":"Blood"},{"key":"8_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1365-2141.2011.08803.x","volume":"155","author":"K Payne","year":"2011","unstructured":"Payne K, Wright P, Grant JW et al (2011) BIOMED-2 PCR assays for IGK gene rearrangements are essential for B-cell clonality analysis in follicular lymphoma. Br J Haematol 155:84\u201392","journal-title":"Br J Haematol"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jmoldx.2015.05.007","volume":"17","author":"D Drandi","year":"2015","unstructured":"Drandi D, Kubiczkova-besse L, Ferrero S et al (2015) Minimal residual disease detection by droplet digital PCR in multiple myeloma, mantle cell lymphoma, and follicular lymphoma. A comparison with real-time PCR. J Mol Diagn 17:652\u2013660","journal-title":"J Mol Diagn"},{"key":"8_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/sj.leu.2404479","volume":"21","author":"PAS Evans","year":"2007","unstructured":"Evans PAS, Pott C, Groenen PJ et al (2007) Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936. Leukemia 21:207\u2013214","journal-title":"Leukemia"},{"key":"8_CR10","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Br\u00fcggemann M et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"key":"8_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/sj.leu.2404586","volume":"21","author":"VH van der Velden","year":"2007","unstructured":"van der Velden VH, Cazzaniga G, Schrauder A et al (2007) Analysis of minimal residual disease by Ig\/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data. Leukemia 21:604\u2013611","journal-title":"Leukemia"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1038\/s41375-019-0496-7","volume":"33","author":"M Br\u00fcggemann","year":"2019","unstructured":"Br\u00fcggemann M, Kotrova M, Knecht H et al (2019) Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study. Leukemia 33:2241\u20132253","journal-title":"Leukemia"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1098-2264(199801)21:1<17::AID-GCC4>3.0.CO;2-B","volume":"21","author":"T Akasaka","year":"1998","unstructured":"Akasaka T, Yonetani N, Ohno H et al (1998) Refinement of the BCL2\/immunoglobulin heavy chain fusion gene in t(14;18)(q32;q21) by polymerase chain reaction amplification for long targets. Genes Chromosom Cancer 21:17\u201329","journal-title":"Genes Chromosom Cancer"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/sj.leu.2401889","volume":"14","author":"G Buchonnet","year":"2000","unstructured":"Buchonnet G, Lenain P, Ruminy P et al (2000) Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3\u2032 BCL2 breakpoints and evidence of a new cluster. Leukemia 14:1563\u20131569","journal-title":"Leukemia"},{"key":"8_CR15","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/sj.leu.2402568","volume":"16","author":"G Buchonnet","year":"2002","unstructured":"Buchonnet G, Jardin F, Jean N et al (2002) Distribution of BCL2 breakpoints in follicular lymphoma and correlation with clinical features: specific subtypes or same disease? Leukemia 16:1852\u20131856","journal-title":"Leukemia"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","volume":"88","author":"CL Rosenberg","year":"1991","unstructured":"Rosenberg CL, Wong E, Petty EM et al (1991) PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci USA 88:9638\u20139642","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR17","first-page":"3188","volume":"5","author":"JP Stewart","year":"2021","unstructured":"Stewart JP, Gazdova J, Darzentas N et al (2021) Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders. Blood Adv 5:3188\u20133198","journal-title":"Blood Adv"},{"key":"8_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.exphem.2006.08.008","volume":"34","author":"M Ladetto","year":"2006","unstructured":"Ladetto M, Mantoan B, De Marco F et al (2006) Cells carrying nonlymphoma-associated bcl-2\/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations. Exp Hematol 34:1680\u20131686","journal-title":"Exp Hematol"},{"key":"8_CR19","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1111\/j.1365-2141.2012.09161.x","volume":"158","author":"E Gimenez","year":"2012","unstructured":"Gimenez E, Chauvet M, Rabin L et al (2012) Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d\u2019Etude des Leuc\u00e9mies et Autres Maladies du Sang. Br J Haematol 158:186\u2013197","journal-title":"Br J Haematol"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","volume":"107","author":"M Br\u00fcggemann","year":"2006","unstructured":"Br\u00fcggemann M, Raff T, Flohr T et al (2006) Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 107:1116\u20131123","journal-title":"Blood"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1073\/pnas.95.4.1460","volume":"95","author":"J SantaLucia","year":"1998","unstructured":"SantaLucia J (1998) A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci USA 95:1460\u20131465","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S0002-9440(10)64905-X","volume":"160","author":"A Albinger-Hegyi","year":"2002","unstructured":"Albinger-Hegyi A, Hochreutener B, Abdou MT et al (2002) High frequency of t(14;18)-translocation breakpoints outside of major breakpoint and minor cluster regions in follicular lymphomas: improved polymerase chain reaction protocols for their detection. Am J Pathol 160:823\u2013832","journal-title":"Am J Pathol"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","volume":"12","author":"MJ Pongers-Willemse","year":"1998","unstructured":"Pongers-Willemse MJ, Verhagen OJ, Tibbe GJ et al (1998) Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes. Leukemia 12:2006\u20132014","journal-title":"Leukemia"},{"key":"8_CR24","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/sj.leu.2401172","volume":"12","author":"C Pott","year":"1998","unstructured":"Pott C, Tiemann M, Linke B et al (1998) Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas. Leukemia 12:1630\u20131637","journal-title":"Leukemia"}],"container-title":["Methods in Molecular Biology","Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4188-0_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T14:05:19Z","timestamp":1729260319000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4188-0_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,19]]},"ISBN":["9781071641873","9781071641880"],"references-count":24,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4188-0_8","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,19]]},"assertion":[{"value":"19 October 2024","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}